Journal of the American Society of Nephrology, Vol 6, 61-67, Copyright © 1995 by American Society of Nephrology

REGULAR ARTICLES

Megalin (gp330) possesses an antigenic epitope capable of inducing passive Heymann nephritis independent of the nephritogenic epitope in receptor-associated protein

RA Orlando, D Kerjaschki and MG Farquhar
Division of Cellular and Molecular Medicine, University of California, San Diego, La Jolla 92093, USA.

The Heymann nephritis antigenic complex (HNAC) consists of two glycoproteins, megalin (gp330), and the receptor-associated protein (RAP). HNAC is expressed on the surface of the glomerular epithelium where it plays a primary role in the pathogenesis of Heymann nephritis (HN). Several models were previously proposed describing how antibody binding epitopes in HNAC may contribute to the initiation and progression of HN. Although these models suggest that nephritogenic epitopes capable of initiating HN are present in both megalin and RAP, the structural relationship between these epitopes has not been established. Previously a nephritogenic epitope was identified and characterized in RAP that initiates immune complex formation in HN. In this report, the immunologic relationship between nephritogenic epitopes in megalin and RAP were examined to determine whether these epitopes are immunologically distinct or antigenically related. To this end, a polyclonal antibody to megalin was generated that does not recognize RAP by immunoblotting or immunoprecipitation and whether this antibody is capable of inducing passive HN was determined. It was found that antimegalin antibodies devoid of RAP cross-reactivity induced the formation of subepithelial immune deposits (passive HN) when injected into rats. Antibodies eluted from glomeruli of the injected rats recognized only megalin by immunoblotting a cortical extract and did not recognize a RAP fusion protein or any other renal protein. In addition, the eluted antibodies immunoprecipitated two proteolytic fragments of megalin (140 and 75 kd) identifying a pathogenic epitope within a smaller fragment of megalin.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. Tramontano, T. Knight, D. Vizzuso, and S. P. Makker Nested N-Terminal Megalin Fragments Induce High-Titer Autoantibody and Attenuated Heymann Nephritis J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1979 - 1985. [Abstract] [Full Text] [PDF]

				G. Chin, G. Luxton, and J. M. Harvey Infliximab and nephrotic syndrome Nephrol. Dial. Transplant., December 1, 2005; 20(12): 2824 - 2826. [Abstract] [Full Text] [PDF]

				A. Tramontano and S. P. Makker Conformation and Glycosylation of a Megalin Fragment Correlate with Nephritogenicity in Heymann Nephritis J. Immunol., February 15, 2004; 172(4): 2367 - 2373. [Abstract] [Full Text] [PDF]

				C. J. I. RAATS, M. E. LUCA, M. A. H. BAKKER, A. VAN DER WAL, P. HEERINGA, H. VAN GOOR, J. VAN DEN BORN, E. DE HEER, and J. H. M. BERDEN Reduction in Glomerular Heparan Sulfate Correlates with Complement Deposition and Albuminuria in Active Heymann Nephritis J. Am. Soc. Nephrol., August 1, 1999; 10(8): 1689 - 1699. [Abstract] [Full Text]

				T. Hiesberger, R. Hodits, R. Ullrich, M. Exner, D. Kerjaschki, W. J. Schneider, and J. Nimpf Receptor-associated Protein and Members of the Low Density Lipoprotein Receptor Family Share a Common Epitope. AN EXTENDED MODEL FOR THE DEVELOPMENT OF PASSIVE HEYMANN NEPHRITIS J. Biol. Chem., November 15, 1996; 271(46): 28792 - 28797. [Abstract] [Full Text] [PDF]

Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673